Author

Jenny Lam

Observed name: JENNY LAM

Institutions: Johnson & Johnson (United States), Actelion (United States)

Observed institutions: Johnson & Johnson (United States), Actelion (United States)

ORCID: 0000-0003-3738-2973

Observed ORCID: 0000-0003-3738-2973

OpenAlex ID: A5128308649

Methamphetamine-associated PAH on the rise in the US: geographic trends & disparities in patient demographics and treatment strategies

2026 · Nick H. Kim, Vinicio de Jesus Perez, et al. · The Journal of Heart and Lung Transplantation · 2

Use of Machine‐Learning Models to Identify Clinical Features Associated With A Future Clinical Worsening Event in Patients With Pulmonary Arterial Hypertension

2026 · Hilary DuBrock, Xiaoqin Tang, et al. · Pulmonary Circulation

Expert Consensus Exploring the Definition of a Disease-modifying Therapy, and the Data Required to Establish a Therapy as Disease-modifying in Pulmonary Arterial Hypertension

2024 · VALLERIE MCLAUGHLIN, ROBERT P FRANTZ, et al. · CHEST Journal

Works count: 3

Citation count: 2

H-index: 1

I10-index: